abs374.txt	we	developed	measures	of	benefits	and	burdens	research	participation	in	cancerclinical	trials	using	a	sequential	mixed	methods	design	with	qualitative	(	n	=32)	quantitative	sample	=	110)	cancer	clinical	trial	participants	benefit-burden	items	(22	for		23	burdens)	were	subsequentlydeveloped	assessed	through	cognitive	interviewing	content	clarity	andmeaning	preliminary	psychometric	analyses	support	the	internal	consistencyreliability	construct	validity	benefit	(Î±	90)	burden	87)research	scales	item	response	theory	models	supported	thediscrimination	ability	on	who	had	thoughtsof	dropping	out	lower	scale	scores	p	<	001)	higher	burdenscores	than	those	no	thoughts	supportingconstruct	further	testing	can	be	used	todevelop	appropriate	interventions	to	address	recruitment	retention	humanparticipants
